Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
236,234,693
-
Total 13F shares
-
15,836,572
-
Share change
-
+1,028,933
-
Total reported value
-
$204,569,610
-
Put/Call ratio
-
21%
-
Price per share
-
$12.92
-
Number of holders
-
88
-
Value change
-
+$19,766,036
-
Number of buys
-
52
-
Number of sells
-
31
Institutional Holders of Akebia Therapeutics, Inc. - Common Stock (AKBA) as of Q4 2015
As of 31 Dec 2015,
Akebia Therapeutics, Inc. - Common Stock (AKBA) was held by
88 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,836,572 shares.
The largest 10 holders included
EAGLE ASSET MANAGEMENT INC, FMR LLC, BlackRock Fund Advisors, Visium Asset Management, LP, FIRST MANHATTAN CO, VANGUARD GROUP INC, BANK OF AMERICA CORP /DE/, BlackRock Institutional Trust Company, N.A., EAM Investors, LLC, and Marshall Wace LLP.
This page lists
88
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.